CA2490896C - Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy - Google Patents

Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy Download PDF

Info

Publication number
CA2490896C
CA2490896C CA2490896A CA2490896A CA2490896C CA 2490896 C CA2490896 C CA 2490896C CA 2490896 A CA2490896 A CA 2490896A CA 2490896 A CA2490896 A CA 2490896A CA 2490896 C CA2490896 C CA 2490896C
Authority
CA
Canada
Prior art keywords
lactic acid
antigen
acid bacteria
blood
ige level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2490896A
Other languages
English (en)
French (fr)
Other versions
CA2490896A1 (en
Inventor
Naoyuki Yamamoto
Yuu Ishida
Izuki Bando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Publication of CA2490896A1 publication Critical patent/CA2490896A1/en
Application granted granted Critical
Publication of CA2490896C publication Critical patent/CA2490896C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA2490896A 2002-06-26 2003-06-26 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy Expired - Fee Related CA2490896C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002185897A JP4212838B2 (ja) 2002-06-26 2002-06-26 抗アレルギー剤
JP2002-185897 2002-06-26
PCT/JP2003/008094 WO2004002501A1 (ja) 2002-06-26 2003-06-26 抗アレルギー剤、アレルギー低減のためのその使用及びアレルギー低減方法

Publications (2)

Publication Number Publication Date
CA2490896A1 CA2490896A1 (en) 2004-01-08
CA2490896C true CA2490896C (en) 2011-02-01

Family

ID=29996753

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2490896A Expired - Fee Related CA2490896C (en) 2002-06-26 2003-06-26 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy

Country Status (21)

Country Link
US (2) US20050214270A1 (cg-RX-API-DMAC10.html)
EP (1) EP1555028B1 (cg-RX-API-DMAC10.html)
JP (1) JP4212838B2 (cg-RX-API-DMAC10.html)
KR (2) KR20080018287A (cg-RX-API-DMAC10.html)
CN (1) CN100567489C (cg-RX-API-DMAC10.html)
AT (1) ATE444074T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003246204B2 (cg-RX-API-DMAC10.html)
BR (1) BR0312052A (cg-RX-API-DMAC10.html)
CA (1) CA2490896C (cg-RX-API-DMAC10.html)
DE (1) DE60329516D1 (cg-RX-API-DMAC10.html)
DK (1) DK1555028T3 (cg-RX-API-DMAC10.html)
ES (1) ES2331180T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA04012636A (cg-RX-API-DMAC10.html)
NO (1) NO20050411L (cg-RX-API-DMAC10.html)
PL (1) PL204931B1 (cg-RX-API-DMAC10.html)
PT (1) PT1555028E (cg-RX-API-DMAC10.html)
RU (1) RU2336886C2 (cg-RX-API-DMAC10.html)
TW (1) TW200402304A (cg-RX-API-DMAC10.html)
UA (1) UA86349C2 (cg-RX-API-DMAC10.html)
WO (1) WO2004002501A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200500715B (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010487A6 (nl) 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
JP4688457B2 (ja) * 2004-09-10 2011-05-25 四国乳業株式会社 免疫増強組成物
JP4823503B2 (ja) * 2004-10-14 2011-11-24 ジェンモント バイオテック インコーポレイテッド Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍの新規微生物株ＧＭ−０９０、およびＩＦＮ−γ分泌の刺激および／またはアレルギーの処置のためのその使用。
US7351572B2 (en) 2004-10-15 2008-04-01 Genmont Biotech Inc. Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
TW200637908A (en) 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
CN101171019B (zh) 2005-03-03 2012-05-23 株式会社明治 免疫功能调节剂
TW200700074A (en) * 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
KR101393718B1 (ko) * 2005-10-11 2014-05-13 프로바이오티컬 에스.피.에이. 비알레르기성 프로바이오틱 박테리아 배양물의 제조 방법 및 관련 용도
WO2007066655A1 (ja) 2005-12-06 2007-06-14 Otsuka Pharmaceutical Co., Ltd. エクオール含有大豆胚軸発酵物、及びその製造方法
DK2068899T3 (da) * 2006-10-02 2015-09-28 Dupont Nutrition Biosci Aps Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner
KR20090092315A (ko) * 2006-12-21 2009-08-31 칼피스가부시키가이샤 ＩｇＡ 생산 촉진제
CA2694354C (en) 2007-07-04 2018-01-16 Kikkoman Corporation Lactic acid bacteria-derived double-stranded rna
RU2431663C2 (ru) * 2008-01-28 2011-10-20 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРОИЗВОДСТВА ИММУНОБИОЛОГИЧЕСКОГО ПРОТИВОАЛЛЕРГИЧЕСКОГО СРЕДСТВА
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
RU2393214C1 (ru) * 2009-01-29 2010-06-27 Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa
RU2460781C2 (ru) * 2009-01-29 2012-09-10 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus, используемый при приготовлении иммунобиологического противоаллергического средства
EP2332557A1 (en) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotic lactic acid bacteria
TW201300526A (zh) * 2011-03-25 2013-01-01 Calpis Co Ltd 培養基之製造方法及該方法所製造之培養基
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
US9636326B2 (en) 2011-12-28 2017-05-02 Maruha Nichiro Corporation Chlorophyll c containing degranulation suppressor
JP6149228B2 (ja) * 2013-04-11 2017-06-21 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
JP5927730B2 (ja) * 2013-04-11 2016-06-01 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
KR101688224B1 (ko) * 2015-05-01 2016-12-20 일동바이오사이언스(주) 관절염 예방 및 치료 효과를 갖는 아이디-씨비티5101(id-cbt5101) 및 이의 용도
JP7030716B2 (ja) * 2016-05-09 2022-03-07 バイオガイア・エイビー アレルギー治療に有用な細菌株の選択
US11260085B2 (en) 2016-09-12 2022-03-01 Ichibiki Co., Ltd. Salt-tolerant lactobacillus, method of culturing salt-tolerant lactobacillus, and immunostimulant
PE20210108A1 (es) 2018-01-12 2021-01-19 Gi Innovation Inc Composicion que comprende probioticos y polipeptido que tiene afinidad de union para ige y uso de la misma
JP2021059522A (ja) * 2019-03-20 2021-04-15 キユーピー株式会社 アレルギー症状改善用組成物
CN116035187B (zh) * 2022-12-30 2025-02-07 江南大学 一种使用植物乳杆菌发酵降低苦杏仁蛋白致敏性的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US575270A (en) * 1897-01-12 Combined cover and stand for books
US635796A (en) * 1898-03-07 1899-10-31 Isaac Moore Manifolding sales-book.
US959766A (en) * 1909-05-14 1910-05-31 Lewis Life Wire-fastener.
US1048383A (en) * 1911-06-16 1912-12-24 Charles J Carroll Manifolding sales-book.
US1201377A (en) * 1916-07-24 1916-10-17 William S Staiars Protector-tablet.
US1915974A (en) * 1930-07-10 1933-06-27 American Sales Book Co Ltd Retaining device
US2218297A (en) * 1936-07-14 1940-10-15 Randzio Reinhold Bookkeeping system
US2806715A (en) * 1956-06-29 1957-09-17 Henry O Smith Illuminated note pad holder
JPH0634709B2 (ja) * 1985-12-03 1994-05-11 カルピス食品工業株式会社 新規乳酸菌
US4787852A (en) * 1987-04-24 1988-11-29 Melnick David W Multicolor interactive notepad
US4840406A (en) * 1987-05-29 1989-06-20 Dennison Manufacturing Company Method of mounting index tabs upon stenographic notebooks
US4816884A (en) * 1987-07-20 1989-03-28 International Business Machines Corporation High density vertical trench transistor and capacitor memory cell structure and fabrication method therefor
WO1995014485A1 (en) * 1993-11-23 1995-06-01 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
CN1110147A (zh) * 1994-04-09 1995-10-18 山田武敏 抗变态反应组合物
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP4064480B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 ＩｇＧ抗体産生抑制剤
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
USD393841S (en) * 1997-05-27 1998-04-28 Fujitsu Limited Renewal of document to make alterations icon for a display screen
US6657642B1 (en) * 1997-07-03 2003-12-02 International Business Machines Corporation User interactive display interfaces with means for interactive formation of combination display objects representative of combined interactive functions
JP2000086524A (ja) * 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
JP2000239175A (ja) * 1999-02-18 2000-09-05 Calpis Co Ltd 抗アレルギー剤
US6217443B1 (en) * 1999-03-11 2001-04-17 Leonard C. Green, Jr. Carbonless paper notepad
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
GB2365659B (en) * 2000-02-25 2002-07-24 Red Fig Ltd Serving hypermedia documents
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
ATE419331T1 (de) * 2000-08-25 2009-01-15 Wakamoto Pharma Co Ltd L. salivarius-stamm enthaltende probiotische produkte
US20030021624A1 (en) * 2001-06-29 2003-01-30 Dorsey Cheryl L. Article and method for making a notebook with permanent and disposable elements
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika

Also Published As

Publication number Publication date
AU2003246204A1 (en) 2004-01-19
DE60329516D1 (de) 2009-11-12
KR100836727B1 (ko) 2008-06-10
PL375158A1 (en) 2005-11-28
BR0312052A (pt) 2005-03-29
AU2003246204B2 (en) 2007-07-12
TW200402304A (en) 2004-02-16
JP2004026729A (ja) 2004-01-29
US8003092B2 (en) 2011-08-23
HK1081432A1 (zh) 2006-05-19
ES2331180T3 (es) 2009-12-23
NO20050411L (no) 2005-01-25
WO2004002501A1 (ja) 2004-01-08
RU2005101766A (ru) 2005-08-20
CN100567489C (zh) 2009-12-09
CN1678330A (zh) 2005-10-05
KR20050014879A (ko) 2005-02-07
KR20080018287A (ko) 2008-02-27
DK1555028T3 (da) 2010-02-01
CA2490896A1 (en) 2004-01-08
US20090047264A1 (en) 2009-02-19
TWI304736B (cg-RX-API-DMAC10.html) 2009-01-01
ZA200500715B (en) 2006-08-30
UA86349C2 (ru) 2009-04-27
US20050214270A1 (en) 2005-09-29
ATE444074T1 (de) 2009-10-15
JP4212838B2 (ja) 2009-01-21
PT1555028E (pt) 2010-01-05
EP1555028B1 (en) 2009-09-30
EP1555028A4 (en) 2007-06-06
PL204931B1 (pl) 2010-02-26
RU2336886C2 (ru) 2008-10-27
MXPA04012636A (es) 2005-03-23
EP1555028A1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
US8003092B2 (en) Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
Kalliomäki et al. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics
KR100406344B1 (ko) 면역을 향상시키는 젖산균
Ishida et al. Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria
AU2007231917B2 (en) Anti-Allergy Lactic Acid Bacteria
US11590180B2 (en) Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving allergic asthma
JPH092959A (ja) ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP2007514738A (ja) 乳酸産生菌及び肺機能
CN113881597B (zh) 一株能够提高吲哚丙烯酸以调节特异性IgE的罗伊氏乳杆菌
SK10662002A3 (sk) Semnogenická aktivita nepatogénnych mliečnych baktérií
CN114958662A (zh) 一株能缓解便秘同时上调il-10缓解炎症的长双歧杆菌长亚种及其应用
CN113913330B (zh) 一株调节OVA特异性IgE的植物乳杆菌及其应用
Lin et al. Induced apoptosis of Th2 lymphocytes and inhibition of airway hyperresponsiveness and inflammation by combined lactic acid bacteria treatment
US20120121753A1 (en) Compositions and methods for prevention and treatment of obesity and obesity related metabolic syndrome
CN111700917B (zh) 一种用于预防和/或治疗特应性皮炎的产品
Fujiwara et al. A double-blind trial of Lactobacillus paracasei strain KW3110 administration for immunomodulation in patients with pollen allergy
CN117305174B (zh) 一株能减轻海马中小胶质细胞激活的乳酸片球菌及其应用
JP5324557B2 (ja) プロバイオティクス菌株ｇｍ−０８０が心臓炎症と心臓細胞アポトーシスの治療に用いられる組成物及びその用途
Cinque et al. Effect of Bifidobacteriuminfantis on Interferon-γ-Induced Keratinocyte Apoptosis: A Potential Therapeutic Approach to Skin Immune Abnormalities
HK1081432B (en) Antiallergic agent, utilization thereof in the manufacture of a medicament for reducing allergy
TWI886566B (zh) 新穎副乾酪乳桿菌副乾酪亞種ａｐｌ００８、其組合物及用途
TW202539716A (zh) 益生菌組合物及其用途
PL236218B1 (pl) Zastosowanie kompozycji probiotycznej
CN120366132A (zh) 一种假小链双歧杆菌aFMT-201、益生菌组合物及在代谢综合征中的应用

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140626